Unlock Scalable, High-Quality AAV Manufacturing with Xcite® Transient Transfection and Stable Producer Cell Line Platforms
Join our experts, Suparna Sanyal and Peng Wang, as they explore innovative solutions for industrial-scale AAV (Adeno-Associated Virus) manufacturing. This session introduces two powerful production platforms: Xcite® Transient Transfection and Stable Producer Cell Lines designed to help gene therapy developers meet growing demands for efficiency, scalability, and quality.
Through real-world case studies and performance data, you'll discover how these platforms streamline both upstream and downstream processes, boost packaging efficiency, and enable seamless scale-up from shake flasks to 250L bioreactors.
We’ll also showcase our proprietary analytical tools, including advanced 3D digital droplet PCR (ddPCR), which deliver deep insights into AAV genome integrity and identity, critical for ensuring product quality. Whether you're working with standard or novel capsids, the Xcite® platform offers unmatched flexibility and performance, achieving titers up to 1E16 VG and packaging efficiencies of over 90%.
For teams focused on reducing the cost of goods and enhancing process robustness, our Stable Producer Cell Line platform offers a transformative alternative. By stably integrating all AAV components into the genome, this system eliminates the need for plasmids and helper viruses, enabling safer, more consistent, and scalable production.
This webinar walks you through the full development journey from GENE sequence to GMP readiness backed by compelling feasibility data and client success stories.
Preview this webinar
Get immediate access to the full webinar by filling out the form on this page.